Sign in

CIK 0001724521 · Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473898435
Phone
(510) 694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
  1. 4 Grant or award Chief Operating Officer acquired 31,000 shares (grant or award)
  2. 4 Gift Chief Executive Officer gave 35,000 shares (gift)
  3. 4 Planned sale President sold 31,823 shares at an average $21.41 ($681,342)
  4. 4 Planned sale Chief Financial Officer sold 6,552 shares at $23.38 ($153,186)
  5. 4 Gift Chief Executive Officer gave 2,400 shares (gift)
  6. 4 Planned sale General Counsel sold 14,468 shares at an average $22.01 ($318,496)
  7. 4 Planned sale Chief Medical Officer sold 9,546 shares at an average $22.01 ($210,144)
  8. 4 Planned sale Chief Accounting Officer sold 8,832 shares at an average $22.13 ($195,434)
  9. 4 Planned sale Chief Financial Officer sold 12,662 shares at an average $22.01 ($278,739)
  10. 4 Planned sale Chief Operating Officer sold 21,208 shares at an average $22.01 ($466,870)
  11. 4 Planned sale President sold 21,208 shares at an average $22.01 ($466,870)
  12. 4 Planned sale Chief Executive Officer sold 54,691 shares at an average $22.01 ($1,203,959)
  13. 4 Planned sale President sold 82,997 shares at $24.71 ($2,050,599)
  14. 4 Planned sale Chief Accounting Officer sold 1,900 shares at $26.00 ($49,400)
  15. 4 Planned sale Chief Financial Officer sold 5,000 shares at $25.00 ($125,000)
  16. 4 Planned sale President sold 50,000 shares at an average $20.26 ($1,012,764)
  17. 4 Planned sale Chief Operating Officer sold 50,291 shares at $18.97 ($954,066)
  18. 4 Planned sale President sold 4,314 shares at $20.32 ($87,650)
  19. 4 Planned sale President sold 96,859 shares at an average $20.76 ($2,010,578)
  20. 4 Planned sale Chief Financial Officer sold 5,000 shares at $20.00 ($100,000)

Page 2 of 15 · 290 filings